Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure US FDA label
Use: INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic solution: 5 mg/5 mg, 8 mg/50 mg
- Ophthalmic solution: 8 mg/mL (0.8 w/v)/50 mg/mL
Registered products in the Philippines
4 products registered with the Food and Drug Administration (FDA) Philippines list Phenylephrine + Tropicamide as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products4
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Auromide PlusTropicamide + Phenylephrine Hydrochloride | 8 mg/mL (0.8 w/v)/ 50 mg/mL (5% w/v) Ophthalmic SolutionWhite Opaque LDPE Dropper Bottle x 5 mL (Box of 1's) | Rx | AurolabIndia | Brady Pharma Inc. | DRP-4021 | Jun 4, 2028 | |
Fenlomax-TTropicamide + Phenylephrine hydrochloride | 8mg/50mg per mL (0.8% w/v / 5.0% w/v) Ophthalmic Solution (Eye Drops)White LDPE Bottle with Screw Cap x 5mL (Box of 1’s) | Rx | Makers Laboratories LtdIndia | Blue Global (FZE) | DRP-18136 | May 13, 2031 | |
Sanmyd-PTropicamide + Phenylephrine Hydrochloride | 5 mg/5 mg per mL (0.5%/ 0.5% w/v) Ophthalmic Solution (Eye Drops)PP Transparent bluish plastic bottle with PE white tip and cap x 10 mL (net content) (Box of 1's) | Rx | Santen Pharmaceutical Co., Ltd. (Shiga Plant)Japan | Importer: Santen Philippines Inc. | DR-XY25408 | Mar 23, 2027 | |
TropisightTropicamide + Phenylephrine Hydrochloride | 8 mg/50 mg per mL (0.8% w/v / 5% w/v) Ophthalmic SolutionLDPE bottle x 5 mL with white nozzle and cap (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Ensight Pharmaceuticals Inc.Trader: Entod Pharmaceuticals Ltd. | DR-XY49588 | Nov 17, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Tropicamide + Phenylephrine Hydrochloride 5 mg + 5 mg/mL, 10 mL Eye Drops | ₱498.75–₱532.00Reference ₱498.75 | per unit | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Tropicamide + phenylephrine hydrochloride |
| PNF listing | Ophthalmic Solution: 5 mg + 5 mg/mL (eye drops) fixed dose combination, 10 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .